Lakozamid'e bağlı gelişen baş ağrısında büyük oksipital sinir blokajına yanıt

References (3)

1. Wiebe S, Téllez-Zenteno JF, Shapiro M. An evidence-based approach to the first seizure. Epilepsia 2008;49 Suppl 1:50- 7. Beydoun A, D'Souza J, Hebert D, Doty P. Lacosamide: phar- macology, mechanisms of action and pooled efficacy and safety data in partial-onset seizures. Expert Rev Neurother 2009;9(1):33-42.
2. Verrotti A, Loiacono G, Pizzolorusso A, Parisi P, Bruni O, Luchetti A, et al. Lacosamide in pediatric and adult patients:comparison of efficacy and safety. Seizure 2013;22(3):210- 6. Krauss GL, Edwards HB, Lin B. Lacosamide for the treat- ment of epilepsy. Ann Med 2012;44(7):674-9. Casas-Fernández C, Martínez-Bermejo A, Rufo-Campos M, Smeyers-Durá P, Herranz-Fernández JL, Ibáñez-Micó S, et al. Efficacy and tolerability of lacosamide in the concomitant treatment of 130 patients under 16 years of age with re- fractory epilepsy: a prospective, open-label, observational, multicenter study in Spain. Drugs R D 2012;12(4):187-97.
3. Inan LE, Inan N, Karadaş Ö, Gül HL, Erdemoğlu AK, Türkel Y, et al. Greater occipital nerve blockade for the treatment of chronic migraine: a randomized, multicenter, double- blind, and placebo-controlled study. Acta Neurol Scand 2015;132(4):270-7.